Inhibikase Therapeutics Inc logo

Inhibikase Therapeutics Inc

1
NAS:IKT (USA)   Ordinary Shares
$ 3.05 -0.01 (-0.33%) 11:09 PM EST
At Loss
Market Cap:
$ 205.61M
Enterprise V:
$ 195.79M
Volume:
58.38K
Avg Vol (2M):
376.03K
Trade In:
Volume:
58.38K
At Loss
Avg Vol (2M):
376.03K

IKT Stock Institutional Ownership and Insider Ownership - Inhibikase Therapeutics Inc

67.19
(Mil)
Shares Outstanding
11.52%
0.86 (Mil)
Institutional Ownership
8.23%
5.53 (Mil)
Insider Ownership 1
79.44%
53.3753 (Mil)
Float Percentage of TSO

Short Interest History (%)

Due to a license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus’ website, except for certain Australian stocks.

Institutional Ownership History (%)

This the Institutional Ownership History of Inhibikase Therapeutics Inc. Peter Lynch prefers to buy companies with low institutional ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Insider ownership (%)

This is the historical insider ownership of Inhibikase Therapeutics Inc. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.
1. Please note that our data vendor collects insider data for officers and directors from Forms 3,4,5 and amendments where they only capture direct ownership data, not indirect ownership.
* Due to varying ownership data coverage and corporate events such as splits, the information in this section is in no way guaranteed for completeness, accuracy or in any other way.

Top Direct Holders

Top Fund Holders